Dr. Ece Cali Daylan joined the Department of Medicine in the Division of Oncology as an assistant professor as of August 2024. She earned her medical degree and PhD in Medical Biology from Hacettepe University, Turkey, before relocating to the United States for advanced training. She completed her internal medicine residency at St. Elizabeth’s Medical Center/Tufts University School of Medicine in Boston, where she was selected for an additional year as Chief Medical Resident. She then pursued a fellowship in Hematology/Medical Oncology at Montefiore Medical Center/Albert Einstein College of Medicine in the Bronx, NY, where she also served as Chief Hematology/Oncology Fellow.
Dr. Cali specializes in the care of patients with lung cancer. Her research focuses on understanding lung cancer subtypes with poor clinical outcomes, aiming to develop treatment and early detection strategies in areas of unmet need. She investigates molecular alterations and cellular pathways that drive lung cancer progression and treatment resistance, with the goal of identifying potential therapeutic targets. In addition to her research, Dr. Cali contributes to the advancement of lung cancer literature as a peer reviewer for multiple oncology journals and as an Editorial Fellow for the Journal of Clinical Oncology (JCO).
As an educator, Dr. Cali has made significant contributions to the teaching and mentoring of medical students and residents. She has led hematology case conferences at Albert Einstein College of Medicine, served as a section leader for the “Medical Interviewing and Doctor-Patient Relationship” course at Tufts University School of Medicine, and organized morbidity and mortality conferences as part of medical grand rounds during the 2020-2021 academic year at St. Elizabeth’s Medical Center. Dr. Cali’s overarching goal is to translate research findings into innovative treatment approaches and design clinical trials of novel therapeutic combinations based on biologically driven rationale to improve outcomes for lung cancer patients.